Abstract
The Qualitator is a daily diary card to measure Quality of Life, developed for use in chemotherapy trials for patients with advanced breast cancer. In a trial at King's College Hospital, 29 patients completed the Qualitator and their scores were compared with scores in the Linear Analogue Self-Assessment and Nottingham Health Profile taken four-weekly. In a separate study at Guy's Hospital, 31 patients completed the diary. The Qualitator offers accurate prognostic data regarding subsequent UICC response and survival and is simple to use.
Publication types
-
Clinical Trial
-
Comparative Study
-
Randomized Controlled Trial
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adult
-
Aged
-
Aged, 80 and over
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Breast Neoplasms / drug therapy
-
Breast Neoplasms / psychology*
-
Cisplatin / administration & dosage
-
Doxorubicin / therapeutic use
-
Epirubicin / therapeutic use
-
Female
-
Fluorouracil / administration & dosage
-
Humans
-
Methotrexate / administration & dosage
-
Middle Aged
-
Patient Compliance
-
Quality of Life*
Substances
-
Epirubicin
-
Doxorubicin
-
Cisplatin
-
Fluorouracil
-
Methotrexate